STLN insider trading — Starling Oncology, Inc.
Over the last 90 days, insiders at Starling Oncology, Inc. (STLN) made 1 open-market purchase worth $78K and 0 open-market sales worth $0, making them net buyers by $78K. The largest purchase was by Chernett Jorey (10% Owner), who bought 12,000 shares for $78K on Aug 14, 2026.
Updated Oct 16, 2026.
Recent STLN insider transactions
Every Form 4 filed by Starling Oncology, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Hively Brad | Director | S · Sale · 10b5-1 | Direct | 298,853 | $6.51 | $1.95M | Form 4 |
| Aug 14, 2026 | Chernett Jorey | 10% Owner | P · Purchase | Direct | 12,000 | $6.54 | $78K | Form 4 |
STLN insider trading FAQ
Are insiders buying STLN stock?
Yes. In the last 90 days, Starling Oncology, Inc. insiders made 1 open-market purchase totaling $78K, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading STLN?
Recent buyers: Chernett Jorey.
Where does STLN insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.